Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function and Performance in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting Post-operatively in the Intensive Care Unit

NCT06090487 is registered in ClinicalTrials.gov with Ain Shams University as lead sponsor.

NCT NCT06090487
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06090487 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function and Performance in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting Post-operatively in the Intensive Care Unit
Lead sponsor
Ain Shams University
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2024
Completion date
March 1, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure